Blueprint Genetics

Blueprint Genetics is a company with strong dedication to genetic diagnostics of hereditary cardiovascular diseases, such as hypertrophic cardiomyopathy (HCM). We provide diagnostics in this field for hundreds of hospitals around the world. We are a Stanford University spin-off founded around proprietary technological innovations that enable high quality genetic diagnostics with faster turn-around-time and lower costs. We are the only company in the world that has our diagnostic platforms based on a unique and novel OS-Seq technology, which was developed by one of our founders at Stanford. This technology was developed to improve clinical genetic diagnostics (Myllykangas et al., 2011. Nature Biotech).  One of the main goals for Blueprint Genetics is to maximize quality in diagnostics.  To achieve this goal we have built a unique analytic pipeline that is formed by our OS-Seq technology, in-house built bioinformatics with incorporated cardiovascular disease variant and knowledge databases, and clinical interpretation by our team of geneticists and physicians with cardiovascular expertise. Our platforms are well designed and comprehensive for all clinical situations. Our laboratory provides test results in average of 21 days and also provide express service with additional costs with 10 day TAT. Please visit the website for additional information: